|
| |
|
This page contains bills sponsored by incumbent Senators who are running for re-election in 2008, plus House incumbents running for Senate in 2008.
Bill sponsorships indicate the topics that legislators are most interested in, and spend the most time on. These bills are selected as the "signature issue" that each legislator focused on.
A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. - Whereas menopause is often a challenging transition for millions of women that requires specialized medications and medical treatments;
- Whereas physicians prescribe a variety of pharmaceutical treatment options to treat women experiencing the symptoms of menopause;
- Whereas individual women respond differently to different treatment options;
- Whereas women's physicians determine on a case-by-case basis which treatment option is optimal for each woman;
- Whereas many physicians prescribe compounded estrogen and other bioidentical hormone treatments for patients for a variety of reasons;
- Whereas many physicians prescribe compounded estrogen treatments that contain estriol to treat menopausal and perimenopausal women;
- Whereas estriol is one of three
estrogens produced by the human body;
- Whereas estriol has been prescribed and used for decades in the United States;
- Whereas the Food and Drug Administration (FDA) has announced that it will no longer permit compounding pharmacists to prepare medications containing estriol pursuant to a doctor's prescription;
- Whereas insurers are now denying women reimbursement for compounded medications containing estriol as a result of the FDA's announcement; and
- Whereas the FDA has acknowledged that it is unaware of any adverse events associated with use of compounded medications containing estriol:
Now, therefore, be it Resolved, That it is the sense of the Congress that--- physicians are in the best position to determine which medications are most appropriate for their patients;
- the FDA should respect the physician-patient relationship; and
- the FDA should reverse its policy that aims to eliminate patients' access to compounded medications containing estriol.
- Topic: Health Care
- Headline: Remove restrictions on estriol (menopause medication)
- Headline 2: Remove restrictions on estriol (menopause medication)
- Key for participation codes:
- Sponsorships: p=sponsored; o=co-sponsored; s=signed
- Memberships: c=chair; m=member; e=endorsed; f=profiled; s=scored
- Resolutions: i=introduced; w=wrote; a=adopted
- Cases: w=wrote; j=joined; d=dissented; c=concurred
Independents
participating in 08-SCR88 |
Total recorded by OnTheIssues:
Democrats:
25
Republicans:
34
Independents:
0 |
|
